Wetzels, S.; Wouters, K.; Schalkwijk, C.G.; Vanmierlo, T.; Hendriks, J.J.A.
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis. Int. J. Mol. Sci. 2017, 18, 421.
https://doi.org/10.3390/ijms18020421
AMA Style
Wetzels S, Wouters K, Schalkwijk CG, Vanmierlo T, Hendriks JJA.
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis. International Journal of Molecular Sciences. 2017; 18(2):421.
https://doi.org/10.3390/ijms18020421
Chicago/Turabian Style
Wetzels, Suzan, Kristiaan Wouters, Casper G. Schalkwijk, Tim Vanmierlo, and Jerome J. A. Hendriks.
2017. "Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis" International Journal of Molecular Sciences 18, no. 2: 421.
https://doi.org/10.3390/ijms18020421
APA Style
Wetzels, S., Wouters, K., Schalkwijk, C. G., Vanmierlo, T., & Hendriks, J. J. A.
(2017). Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis. International Journal of Molecular Sciences, 18(2), 421.
https://doi.org/10.3390/ijms18020421